Paper11675330
Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes.
Wurbel MA and 7 others. Blood, 2001. Cited by 241 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes. Papers, record 11675330. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11675330
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| Intestine, Small | Major topic |
| Receptors, Antigen, T-Cell, gamma-delta | Major topic |
| Receptors, Chemokine | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Cell Count | |
| Cell Differentiation | |
| Cell Division | |
| Chemokines, CC | |
| Chemotaxis | |
| Epithelial Cells | |
| Fetus | |
| Mice | |
| Mice, Knockout | |
| Receptors, CCR | |
| Thymus Gland |
Source PubMed
Cited by103
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 241 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,742,894 | Mendelian randomization analysis of inflammatory proteins and lung adenocarcinoma risk. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42742894 | PubMed |
| 42,720,090 | Immune regulation of neuronal stem cells in the medaka retina. | Development | 2026 | https://conductscience.org/library/papers/42720090 | PubMed |
| 42,653,276 | Intestinal Epithelial MHC-II at the Interface of Microbiota, Immunity, and Inflammation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653276 | PubMed |
| 42,349,656 | GPR15-GPR15L axis controls colon natural TCRαβ cells residency and enteroendocrine cell homeostasis to calibrate metabolism. | Mucosal Immunol | 2026 | https://conductscience.org/library/papers/42349656 | PubMed |
| 42,118,152 | Epithelial chemokine CCL25 integrates T cell development and intestinal homeostasis. | J Exp Med | 2026 | https://conductscience.org/library/papers/42118152 | PubMed |
| 40,305,493 | CCR9 shapes the immune microenvironment of colorectal cancer modulating the balance between intratumoral CD8+ T cell and FoxP3+ Helios+ Treg subpopulations. | PLoS One | 2025 | https://conductscience.org/library/papers/40305493 | PubMed |
| 39,257,583 | The thymus road to a T cell: migration, selection, and atrophy. | Front Immunol | 2024 | https://conductscience.org/library/papers/39257583 | PubMed |
| 39,192,970 | Acute T-cell lymphoblastic leukemia: chimeric antigen receptor technology may offer a new hope. | Front Immunol | 2024 | https://conductscience.org/library/papers/39192970 | PubMed |
| 39,040,069 | Vhl safeguards thymic epithelial cell identity and thymopoietic capacity by constraining Hif1a activity during development. | iScience | 2024 | https://conductscience.org/library/papers/39040069 | PubMed |
| 38,571,951 | Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis. | Front Immunol | 2024 | https://conductscience.org/library/papers/38571951 | PubMed |
| 38,339,023 | Interplay between Microbiota and γδ T Cells: Insights into Immune Homeostasis and Neuro-Immune Interactions. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38339023 | PubMed |
| 37,468,610 | Chimeric antigen receptor T cells march into T cell malignancies. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37468610 | PubMed |
| 37,398,661 | The intestinal γδ T cells: functions in the gut and in the distant organs. | Front Immunol | 2023 | https://conductscience.org/library/papers/37398661 | PubMed |
| 36,925,684 | Integrated role of human thymic stromal cells in hematopoietic stem cell extravasation. | Bioeng Transl Med | 2023 | https://conductscience.org/library/papers/36925684 | PubMed |
| 36,569,835 | Development and function of natural TCR+ CD8αα+ intraepithelial lymphocytes. | Front Immunol | 2022 | https://conductscience.org/library/papers/36569835 | PubMed |
| 36,552,738 | Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare? | Cells | 2022 | https://conductscience.org/library/papers/36552738 | PubMed |
| 35,967,322 | Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumors. | Front Immunol | 2022 | https://conductscience.org/library/papers/35967322 | PubMed |
| 35,778,600 | Chemokine receptor CCR9 suppresses the differentiation of CD4+CD8αα+ intraepithelial T cells in the gut. | Mucosal Immunol | 2022 | https://conductscience.org/library/papers/35778600 | PubMed |
| 35,422,795 | Three Layers of Intestinal γδ T Cells Talk Different Languages With the Microbiota. | Front Immunol | 2022 | https://conductscience.org/library/papers/35422795 | PubMed |
| 35,380,608 | IL-17A-producing γδT cells promote muscle regeneration in a microbiota-dependent manner. | J Exp Med | 2022 | https://conductscience.org/library/papers/35380608 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11675330
GET https://conductscience.org/api/papers/v1/11675330/cited_by?page=2